Search

Your search keyword '"Miorin L"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Miorin L" Remove constraint Author: "Miorin L"
88 results on '"Miorin L"'

Search Results

1. A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners

7. Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis

10. Nefropatia.

11. Three-Dimensional Architecture of Tick-Borne Encephalitis Virus Replication Sites and Trafficking of the Replicated RNA

12. Formation of membrane-defined compartments by tick-borne encephalitis viruscontributes to the early delay in interferon signaling

13. Visual detection of Flavivirus RNA in living cells

14. TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment.

15. Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19.

16. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

17. The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection.

18. Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.

19. Fatal COVID-19 pulmonary disease involves ferroptosis.

20. Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury.

21. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.

22. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.

23. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing.

24. SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation.

25. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.

26. Interaction between chicken TRIM25 and MDA5 and their role in mediated antiviral activity against IBDV infection.

27. Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

28. Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.

29. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera.

30. SLiMs go viral! One more weapon against interferon.

31. The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters.

32. Functional Effects of Cardiomyocyte Injury in COVID-19.

33. A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners.

34. The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus.

35. African Swine Fever Virus Induces STAT1 and STAT2 Degradation to Counteract IFN-I Signaling.

36. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.

37. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.

38. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.

39. Functional landscape of SARS-CoV-2 cellular restriction.

40. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.

41. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.

42. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.

43. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.

44. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.

45. The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.

46. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.

47. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

48. Physiology of cardiomyocyte injury in COVID-19.

49. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.

50. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

Catalog

Books, media, physical & digital resources